Nucleic Acids Research Cover Letter: What Editors Actually Need to See
NAR has a resubmission disclosure rule that trips up returning authors. If you previously submitted any version of this manuscript to NAR and it was rejected, you must disclose the prior manuscript number and explain what changed.
Readiness scan
Before you submit to Nucleic Acids Research, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Nucleic Acids Research at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 13.1 puts Nucleic Acids Research in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~45% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Nucleic Acids Research takes ~45 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Getting the structure, tone, and decision logic right before you send anything out. |
Most important move | Make the reviewer-facing or editor-facing ask obvious early rather than burying it in prose. |
Common mistake | Turning a practical page into a long explanation instead of a working template or checklist. |
Next step | Use the page as a tool, then adjust it to the exact manuscript and journal situation. |
Quick answer: a strong NAR cover letter states scope fit, confirms free data and tool access, specifies the article type, and discloses any prior NAR submission. The resubmission disclosure rule is the single most NAR-specific requirement and the one most often missed.
What NAR Editors Screen For
Criterion | What They Want | Common Mistake |
|---|---|---|
Prior submission disclosure | If any version was previously submitted to NAR and rejected, the prior manuscript number must be disclosed | Failing to disclose prior NAR submissions - the editorial office tracks them |
Free access | All tools, databases, and datasets must be freely accessible without login | Requiring registration or restricting access to described resources |
Article type | Correct type specified (Research, Web Server Issue, Database Issue, etc.) | Mismatch between content and article type or missing special-issue proposal |
Scope fit | Nucleic acid biology, genomics, tools for nucleic acid research | Submitting general biology or methods work without a nucleic acids connection |
Data availability | Sequencing data deposited in public repositories with accession numbers | Vague data-availability statements without specific accessions |
What the official sources do and do not tell you
The NAR author guidelines explain formatting, data-availability policies, and special-issue timelines. They do clearly state the resubmission disclosure rule and the free-access requirement for tools and databases.
What the guidelines imply but do not emphasize:
- the editorial office uses ScholarOne logs to identify undisclosed resubmissions, so trying to skip disclosure will be caught
- Web Server Issue cover letters must list competing tools with their URLs (this is a hard requirement, not a suggestion)
- tools requiring login or registration are not accepted, period
- the free-data requirement applies to all article types, not just special issues
What the editor is really screening for
At triage, the editor is asking:
- does this paper have a clear connection to nucleic acid biology, genomics, or related methodology?
- is the main finding stated directly, not hedged?
- are all tools, code, and data freely accessible at the provided URLs right now, not "upon acceptance"?
- if this is a resubmission, was it disclosed honestly with a point-by-point response?
For Web Server and Database submissions, the editor also checks whether the proposal was previously accepted (submitting to a special issue without a prior accepted proposal results in administrative rejection).
What a strong NAR cover letter should actually do
A strong letter usually does five things:
- states the scientific question and the main finding directly
- specifies the article type (Research Article, Brief Communication, Survey and Summary, or special issue)
- confirms free access to all tools, code, and data with URLs
- discloses any prior NAR submission with manuscript number and revision summary
- for Web Server Issue papers, lists competing tools with URLs
What the official NAR workflow makes important
According to the author guidelines and special-issue instructions, the cover letter at Nucleic Acids Research is partly scientific framing and partly operational disclosure. In practice, the editor wants immediate answers to questions that can otherwise trigger administrative rejection:
- what article type is this
- are the tools, datasets, or servers freely available right now
- is there any prior NAR submission history that must be disclosed
- for special issues, were the proposal rules followed
That makes NAR different from journals where the letter is mostly optional persuasion. Here, a clean letter reduces both scope ambiguity and process friction.
In our pre-submission review work
Editors actually react badly to avoidable operational omissions. We see this pattern when the science may be appropriate, but the cover letter never confirms free access, never specifies article type, or leaves a prior NAR rejection undisclosed even though the editorial system can connect the history.
What actually happens at triage is a scientific-fit check layered on top of a process-compliance check. In our review work, the stronger letters handle the operational details quickly and then spend the remaining space on the nucleic-acid biology or method contribution. The weaker ones read like generic molecular-biology letters and miss the NAR-specific rules entirely.
This is where good submissions create unnecessary risk. If the manuscript is viable, the letter should make the compliance story effortless for the editor.
A practical template you can adapt
Dear Editors of Nucleic Acids Research,
We submit "[TITLE]" for consideration as a [Research Article / Brief
Communication / Survey and Summary] in Nucleic Acids Research.
[1-2 sentences: the open question this work addresses.]
[1-2 sentences: the main finding, stated directly.]
[1-2 sentences: why this matters to the NAR readership.]
[If resubmission: This manuscript was previously submitted under
manuscript number [NAR-XXXXX-X-XXXX] and was returned on [date].
We have addressed all concerns. A point-by-point response is
uploaded separately. Authorship changes: [none / describe].]
All data and code are freely available at [URL] without login.
The authors declare no competing interests.
Sincerely,
[Name, Affiliation]For Web Server Issue submissions, add after the main finding:
The following existing web servers perform related computations:
- [Tool A]: [URL] - [brief description]
- [Tool B]: [URL] - [brief description]
- [Tool C]: [URL] - [brief description]
Our tool differs by [1-2 sentences].
[Tool name] is freely accessible at [URL] without registration.Mistakes that make these letters weak
The common failures are:
- failing to disclose a prior NAR submission (the editorial office will find it)
- not listing competing tools in Web Server Issue submissions
- requiring login for yManusights or database
- using a vague data-availability statement ("available upon request")
- submitting to a special issue without a prior accepted proposal
- writing a generic cover letter with no NAR-specific content
Submit if / Think twice if
Submit if:
- the nucleic-acid connection is central and easy to explain in one paragraph
- all linked tools, datasets, and code are already accessible under the journal's rules
- you can disclose prior NAR history cleanly without creating ambiguity
Think twice if:
- the paper is fundamentally broader molecular biology with only a light nucleic-acids angle
- any server, dataset, or software access still depends on login, approval, or future release
- the article type or special-issue pathway is still unsettled
Readiness check
Run the scan while Nucleic Acids Research's requirements are in front of you.
See how this manuscript scores against Nucleic Acids Research's requirements before you submit.
What should drive the submission decision instead
Before polishing the letter further, confirm the journal fit is honest.
The better next reads are:
- NAR review time
- NAR submission process
- NAR submission guide
If the paper is primarily a biological finding enabled by genomic data, Genome Biology may be a better fit. If it is a new method with broad life-sciences applicability, Nature Methods is the higher-impact option.
Practical verdict
The strongest NAR cover letters are operationally precise: they specify the article type, confirm free access, and handle disclosure cleanly. The resubmission rule is the one NAR-specific detail that most authors miss, and it is the one editors notice most.
A NAR cover letter framing check is the fastest way to pressure-test whether your framing meets the editorial bar before submission.
Before you submit
A NAR cover letter and submission readiness check is most useful when the science may fit, but the article type, access requirements, or resubmission disclosure still need a hard editorial read before you submit.
Frequently asked questions
Yes. If any version of the manuscript was previously submitted to NAR and rejected, you must disclose the prior manuscript number, upload a point-by-point response, and note any authorship changes. The editorial office tracks prior submissions.
Approximately 44 percent. NAR publishes around 1,242 articles per year. Acceptance rates vary by article type; Web Server Issue and Database Issue papers have separate timelines.
Yes. All databases, web servers, programs, and datasets must be freely accessible without login or registration. The only exception is legally protected human data. This applies to regular articles and special issues.
The Web Server Issue (July) and Database Issue (January). Both require a one-page proposal submitted months before the manuscript deadline. Cover letters for Web Server submissions must list competing tools with URLs.
Sources
- 1. NAR author guidelines, Oxford University Press.
- 2. NAR Web Server Issue call for papers, Oxford University Press.
- 3. NAR Database Issue call for papers, Oxford University Press.
- 4. ScholarOne submission portal for NAR, Oxford University Press.
- 5. Clarivate Journal Citation Reports, 2025 release.
Final step
Submitting to Nucleic Acids Research?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Nucleic Acids Research submission guide
- How to Avoid Desk Rejection at Nucleic Acids Research (2026)
- Nucleic Acids Research Review Time 2026: How Long to First Decision?
- Bioinformatics vs Nucleic Acids Research
- Nucleic Acids Research Acceptance Rate: What Authors Can Actually Use
- Nucleic Acids Research APC and Open Access: Current OUP Pricing, Agreements, and the Real Value Question
Supporting reads
Conversion step
Submitting to Nucleic Acids Research?
Anthropic Privacy Partner. Zero-retention manuscript processing.